Cargando…

Five cases of childhood-onset Graves’ disease treated with either surgery or radio-iodine therapy

There are three major therapeutic options for the treatment of Graves’ disease (GD): antithyroid drugs (ATDs), thyroidectomy, and radio-iodine (RAI) therapy. ATDs are the initial treatment option for children. However, some pediatric GD patients who are initially treated with ATDs require other type...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomari, Kouki, Goto, Masahiro, Shimada, Aya, Yagi, Hiroko, Nagashima, Yuka, Hasegawa, Yukihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society for Pediatric Endocrinology 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627228/ https://www.ncbi.nlm.nih.gov/pubmed/29026276 http://dx.doi.org/10.1297/cpe.26.265

Ejemplares similares

The assessment of radio-adaptive response in graves' hyperthyroidism patients following radioactive iodine uptake
por: Fazeli, Zahra, et al.
Publicado: (2018)

Early-onset urological disorders due to Wolfram syndrome: A case of neonatal onset
por: Fukuma, Mami, et al.
Publicado: (2016)

Clinical experience with radioactive iodine in the treatment of childhood and adolescent Graves' disease
por: Cury, Adriano N, et al.
Publicado: (2012)

A case of spondyloepiphyseal dysplasia tarda caused by a novel intragenic deletion of TRAPPC2
por: Takagi, Masaki, et al.
Publicado: (2015)

Iodine Content and Distribution in Thyroid Specimens from Two Patients with Graves' Disease Pretreated with Either Propylthiouracil or Stable Iodine: Analysis Using X-Ray Fluorescence and Time-of-Flight Secondary Ion Mass Spectrometry
por: Hansson, Marie, et al.
Publicado: (2012)

Application of oral inorganic iodine in the treatment of Graves’ disease
por: Huang, Yixuan, et al.
Publicado: (2023)

Sexual precocity in a girl with early-onset Graves’ disease
por: Ogawa, Eishin, et al.
Publicado: (2018)

A Convenient Route to New (Radio)Fluorinated and (Radio)Iodinated Cyclic Tyrosine Analogs
por: Chao, Maria Noelia, et al.
Publicado: (2022)

Change in BMI after radioactive iodine ablation for graves disease
por: Chen, Melinda, et al.
Publicado: (2017)

Clinical Outcomes of Repeated Radioactive Iodine Therapy for Graves’ Disease
por: Kim, Min Joo, et al.
Publicado: (2022)

Guidelines for the treatment of childhood-onset Graves’ disease in Japan, 2016
por: Minamitani, Kanshi, et al.
Publicado: (2017)

Thyroid Isthmus Length and Iodine Turnover as Predictors of Successful Radioactive Iodine Therapy in Patients with Graves' Disease
por: Park, Se Hee, et al.
Publicado: (2017)

Novel heterozygous mutation in the extracellular domain of FGFR1 associated with Hartsfield syndrome
por: Takagi, Masaki, et al.
Publicado: (2016)

Anaplastic Thyroid Carcinoma Following Radioactive Iodine Therapy for Graves' Disease
por: Kim, Sun Hwa, et al.
Publicado: (2013)

Iodine-131 induced hepatotoxicity in previously healthy patients with Grave’s disease
por: Jhummon, Navina Priya, et al.
Publicado: (2013)

Chylothorax Associated with Substernal Goiter in Graves’ Disease Treated with Radioactive Iodine
por: Young Oh, Seo, et al.
Publicado: (2017)

Graves' Disease-Related Pancytopenia Improved after Radioactive Iodine Ablation
por: Hamid, Omnia A., et al.
Publicado: (2020)

Effect of liver dysfunction on outcome of radioactive iodine therapy for Graves’ disease
por: Ze, Yuyang, et al.
Publicado: (2022)

Iodine in the Therapy of Graves' Disease: A Century After Henry S. Plummer
por: Kopp, Peter A.
Publicado: (2023)

Association between radioactive iodine uptake and neutropenia in untreated Graves’ disease
por: Yang, Qian, et al.
Publicado: (2023)

Five-Year Survival Is Similar in Thyroid Cancer Patients with Distant Metastases Prepared for Radioactive Iodine Therapy with either Thyroid Hormone Withdrawal or Recombinant Human TSH
por: Tala, H., et al.
Publicado: (2011)

Treatment of Graves’ Disease With a Combination of Low Iodine Diet and Potassium Iodide Plus Radioactive Iodine Treatment
por: Ebrahim, Ismail, et al.
Publicado: (2021)

The prevalence and significance of nonuniform thyroid radio‐isotope uptake in patients with Graves’ disease
por: Abdalaziz, Altayeb, et al.
Publicado: (2022)

Iodination of terminal alkynes using KI/CuSO(4) – A facile method with potential for radio-iodination
por: Ferris, Trevor, et al.
Publicado: (2019)

Frequent and prolonged administration of glucocorticoid for acute adrenal insufficiency treatment can cause diabetes mellitus: A case of holoprosencephaly
por: Karashima, Ryoko, et al.
Publicado: (2019)

Acute psychosis caused by hypothyroidism following radioactive iodine treatment of Graves' disease
por: Hyams, Catherine, et al.
Publicado: (2013)

Thyroid storm following radioactive iodine (RAI) therapy for pediatric graves disease
por: Rohrs, Henry J., et al.
Publicado: (2014)

Factors Predicting Treatment Failure in Patients Treated with Iodine-131 for Graves’ Disease
por: Manohar, Kuruva, et al.
Publicado: (2013)

Graves’ disease in children in the two decades following implementation of an iodine prophylaxis programme
por: Borowiec, Ada, et al.
Publicado: (2018)

A Case for Lithium Pretreatment Prior to Radioactive Iodine Ablation in Grave’s Disease
por: Thakkar, Aditi, et al.
Publicado: (2021)

FRI494 Ischemic Stroke After Radioactive Iodine Therapy In Graves Disease
por: Rave, Talia, et al.
Publicado: (2023)

Abstract #1399287: New-Onset Thyroid Eye Disease After COVID-19 Infection in Patient with Graves’ Disease Post-Radioactive Iodine Treatment
por: Baghdy, Sandy, et al.
Publicado: (2023)

Administration of thiamazole for Graves’ disease might trigger the onset of type 1 diabetes
por: Mizutani, Gen, et al.
Publicado: (2018)

No impact of dietary iodine restriction in short term development of hypothyroidism following fixed dose radioactive iodine therapy for Graves’ disease
por: Jacob, Jubbin Jagan, et al.
Publicado: (2015)

Pinworm infection – Ovulation at midnight
por: Tomari, Kouki, et al.
Publicado: (2017)

PSAT345 Neonatal Graves (NG) Affecting 3 Newborns of a Mother Treated with Radioactive Iodine (RAI) for Graves’ Disease (GD)
por: Ali, Dalal S, et al.
Publicado: (2022)

Risk factors of hepatic dysfunction in patients with Graves’ hyperthyroidism and the efficacy of (131)iodine treatment
por: Wang, Renfei, et al.
Publicado: (2017)

Predictive factors for the outcomes of Graves’ disease patients with radioactive iodine ((131)I) treatment
por: Xing, Yu-Zhuo, et al.
Publicado: (2020)

Predictive factors for early hypothyroidism following the radioactive iodine therapy in Graves’ disease patients
por: Hu, Rui-Ting, et al.
Publicado: (2020)

The ultimate radiochemical nightmare: upon radio-iodination of Botulinum neurotoxin A, the introduced iodine atom itself seems to be fatal for the bioactivity of this macromolecule
por: van Uhm, Janneke IM, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_90sp638ph88rgg481fir4iil18